Cargando…
Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis
BACKGROUND: There is now good evidence that antiplatelet agents (principally low dose aspirin) prevent pre-eclampsia, a leading cause of morbidity and mortality for pregnant women and their babies. A Cochrane Review identified moderate, but clinically important, reductions in the relative risks of p...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555958/ https://www.ncbi.nlm.nih.gov/pubmed/15833147 http://dx.doi.org/10.1186/1471-2393-5-7 |
Ejemplares similares
-
PROVE—Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
por: Bergman, Lina, et al.
Publicado: (2021) -
Tests for predicting complications of pre-eclampsia: A protocol for systematic reviews
por: Thangaratinam, Shakila, et al.
Publicado: (2008) -
Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy
por: Cnossen, Jeltsje S, et al.
Publicado: (2006) -
External validation, update and development of prediction models for pre-eclampsia using an Individual Participant Data (IPD) meta-analysis: the International Prediction of Pregnancy Complication Network (IPPIC pre-eclampsia) protocol
por: Allotey, John, et al.
Publicado: (2017) -
Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial
por: Lin, Li, et al.
Publicado: (2018)